Directory Antineoplastic funds Antineoplastic hormonal and hormone antagonists Aromazin
This page is translated automatically with a help of Google Translate

Аромазин

See also Exemestane

Roman name

Aromasin

Pharmacokinetics

After intake of rapidly absorbed, C_max achieved within 2 h, has been associated with the plasma protein by 90%, T_1/2 about 24 hours, easily penetrates the tissues. Inaguiruetsa oxidation of methylene groups in the position in June with the participation of izofermenta CYP 3A4 and / or rehabilitation 17-ketogroup альдокеторедуктазами . Provided, incl. in the form of metabolites in urine (unchanged to less than 1% of dose) and spread over one week.

Clinical pharmacology

Reduced estrogen concentrations in the plasma of women in postmenopause is the dose of 5 mg and reaches its maximum (more than 90%) at doses of 10-25 mg. The patients in постменопаузе with breast cancer under the influence of dose of 25 mg ароматазы activity is reduced by 98%.

Indications

Breast cancer among women postmenopause (natural or induced), advanced against antiestrogenami therapy, steroid inhibitors aromataza or progestinami.

Pregnancy and lactation

Contraindicated.

Contraindications

Hypersensitivity, the children's age.

Patient interaction

Эстрогенсодержащие drugs nullify effects.

Precautions

Not recommended for women in predmenopause. Postmenopausny status to the definition of source, and opened seconds.

Storage conditions

The temperature does not exceed 30 ° C

Shelf life

3 years

The registration

011835/01-2000

The drug forms

Today, dvoyakovpuklae pill white with a slight sheen serovatam Sugar-coated diameter of about 6 mm, with the inscription in the form of numbers in 7663 carried out by the black print painted on one of the parties.

All products of this group